From Norwich Research Park.
UK Charity Invest in ME Research is awarding £625,000 for continued research into the disease myalgic encephalomyelitis (ME or ME/CFS), including a clinicial trial at the Quadram Institute.
This major investment is an increase of the charity’s previous pledge of £500,000 that was announced in late 2019.
This research builds on the foundations already made for a UK/European Centre of Excellence for ME research hub in Norwich Research Park.
The new pledge will cover the required funding for a clinical trial of Faecal Microbiota Transplantation (FMT) being performed alongside other high-quality biomedical research at the Quadram Institute (QI).
QI’s world-class facility has already seen five PhDs employed on research into ME, focusing specifically on the gut microbiota and links to ME.
The charity has committed to award £45,000 to co-fund the latest PhD studentship with the University of East Anglia.
Invest in ME Research Chairman Kathleen McCall said: “The charity and its dedicated supporters have continued to develop a strategy of high-quality biomedical research in partnership with world-class institutes at one of the most outstanding research parks in Europe.
To read the rest of this story, click on the link below: